Wang Bing, Dai Yeneng, Kong Yingjie, Du Wenyu, Ni Haiyang, Zhao Honghai, Sun Zhiquan, Shen Qingming, Li Meixing, Fan Quli
Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, Nanjing 210023, China.
ACS Appl Mater Interfaces. 2020 Dec 2;12(48):53634-53645. doi: 10.1021/acsami.0c14046. Epub 2020 Nov 18.
The development of effective and safe tumor nanotheranostics remains a research imperative. Herein, tumor microenvironment (TME)-responsive Fe(III)-porphyrin (TCPP) coordination nanoparticles (FT@HA NPs) were prepared using a simple one-pot method followed by modification with hyaluronic acid (HA). FT@HA NPs specifically accumulated in CD44 receptor-overexpressed tumor tissues through the targeting property of HA and upon endocytosis by tumor cells. After cell internalization, intracellular acidic microenvironments and high levels of glutathione (GSH) triggered the rapid decomposition of FT@HA NPs to release free TCPP molecules and Fe(III) ions. The released Fe(III) ions could trigger GSH depletion and Fenton reaction, activating chemodynamic therapy (CDT). Meanwhile, the fluorescence and photodynamic effects of the TCPP could be also activated, achieving controlled reactive oxygen species (ROS) generation and avoiding side effects on normal tissues. Moreover, the rapid consumption of GSH further enhanced the efficacy of CDT and photodynamic therapy (PDT). The experiments further demonstrated that the antitumor effect of these nanotheranostics was significantly enhanced and that their toxicity and side effects against normal tissues were effectively suppressed. The FT@HA NPs can be applied for activated tumor combination therapy under the guidance of dual-mode imaging including fluorescence imaging and magnetic resonance imaging, providing an effective strategy for the design and preparation of TME-responsive multifunctional nanotheranostics for precise tumor imaging and combination therapy.
开发有效且安全的肿瘤纳米诊疗剂仍然是一项研究要务。在此,采用简单的一锅法制备了肿瘤微环境(TME)响应性铁(III)-卟啉(TCPP)配位纳米颗粒(FT@HA NPs),随后用透明质酸(HA)进行修饰。FT@HA NPs通过HA的靶向特性特异性地积聚在CD44受体过表达的肿瘤组织中,并被肿瘤细胞内吞。细胞内化后,细胞内酸性微环境和高水平的谷胱甘肽(GSH)触发FT@HA NPs快速分解,释放出游离的TCPP分子和铁(III)离子。释放出的铁(III)离子可引发GSH消耗和芬顿反应,激活化学动力疗法(CDT)。同时,TCPP的荧光和光动力效应也可被激活,实现活性氧(ROS)的可控生成,并避免对正常组织产生副作用。此外,GSH的快速消耗进一步增强了CDT和光动力疗法(PDT)的疗效。实验进一步证明,这些纳米诊疗剂的抗肿瘤效果显著增强,且对正常组织的毒性和副作用得到有效抑制。FT@HA NPs可用于在包括荧光成像和磁共振成像在内的双模成像引导下的激活肿瘤联合治疗,为设计和制备用于精确肿瘤成像和联合治疗的TME响应性多功能纳米诊疗剂提供了一种有效策略。